In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Orthovita completes private equity financing

Executive Summary

Orthovita Inc. (US orthopedics company that went public on Easdaq in 1998) grossed $7mm in the private sale of 1.2mm common shares to the Rennes Foundation, a private organization in Liechtenstein that already owned a small percentage of the company's stock. Rennes paid $5.90 per share (market price); Orthovita's 13G filing with the SEC shows that the foundation now owns 11.9% of the company.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies